REGENXBIO Inc.

REGENXBIO Inc.

HQ
Rockville, MD
374 Total Employees
Year Founded: 2008

Jobs at Similar Companies

Boston, MA
Hybrid
Clayton, NC, United States
Hybrid

Similar Companies Hiring

Software • Pharmaceutical • Manufacturing • Healthtech • Biotech • Analytics
4 Offices
50000 Employees
Machine Learning • Design • Biotech • Artificial Intelligence
Boston, MA
95 Employees
Software • Pharmaceutical • Machine Learning • Biotech • Big Data • Artificial Intelligence • Analytics
11 Offices
63000 Employees

REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (AAV) gene therapy. REGENXBIO's NAV® Technology Platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on REGENXBIO's NAV Technology Platform. REGENXBIO seeks to accomplish this mission through a combination of internal development efforts and third‐party NAV Technology Platform licensees.


REGENXBIO Inc. Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site: None
HQ Rockville, MD